Plunkett Research Online: Antares Pharma Inc

ANTARES PHARMA INC (ATRS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Antares Pharma, Inc. develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector and pen injector systems. The Company’s injection device platform features three main.....



Antares Pharma Inc
Ticker: ATRS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 609 359-3020
Fax: 610 458-0756
Address: 100 Princeton South
Suite 300
Ewing, NJ 08628 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Surgical and Medical Instrument Manufacturing
ContactsDescription
Robert AppleCEO/Director/President
Fred PowellCFO/Chief Accounting Officer/Executive VP
See More
Antares Pharma, Inc. develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector and pen injector systems. The Company’s injection device platform features three main.....See More See More

Auditor: KPMG LLP
Legal Advisor: Morgan, Lewis & Bockius
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: